P1584: CELLULAR IMMUNE RESPONSE TO THE BNT162B2 VACCINE IN LYMPHOMA PATIENTS
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000849192.25628.25 |
| _version_ | 1797288023061168128 |
|---|---|
| author | R. Gurion U. Rozovski G. Itchaki A. Gafter-Gvili C. Leibovitch P. Raanani M. Szwarcwort M. Taylor-Abigadol E. Dann N. Horesh T. Inbar I. Tzoran N. Lavi E. Bar Haim H. Cohen I. Slouzky T. Azoulay M. Karmona S. Ringelstein-Harlev N. A. Horowitz |
| author_facet | R. Gurion U. Rozovski G. Itchaki A. Gafter-Gvili C. Leibovitch P. Raanani M. Szwarcwort M. Taylor-Abigadol E. Dann N. Horesh T. Inbar I. Tzoran N. Lavi E. Bar Haim H. Cohen I. Slouzky T. Azoulay M. Karmona S. Ringelstein-Harlev N. A. Horowitz |
| author_sort | R. Gurion |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:42:19Z |
| format | Article |
| id | doaj.art-3e35c6bf006048e7a96d37648cac9701 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:42:19Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-3e35c6bf006048e7a96d37648cac97012024-03-02T03:29:11ZengWileyHemaSphere2572-92412022-06-0161465146610.1097/01.HS9.0000849192.25628.25202206003-01465P1584: CELLULAR IMMUNE RESPONSE TO THE BNT162B2 VACCINE IN LYMPHOMA PATIENTSR. Gurion0U. Rozovski1G. Itchaki2A. Gafter-Gvili3C. Leibovitch4P. Raanani5M. Szwarcwort6M. Taylor-Abigadol7E. Dann8N. Horesh9T. Inbar10I. Tzoran11N. Lavi12E. Bar Haim13H. Cohen14I. Slouzky15T. Azoulay16M. Karmona17S. Ringelstein-Harlev18N. A. Horowitz191 Hematology, Rabin Medical Center, Petach Tikva1 Hematology, Rabin Medical Center, Petach Tikva1 Hematology, Rabin Medical Center, Petach Tikva1 Hematology, Rabin Medical Center, Petach Tikva1 Hematology, Rabin Medical Center, Petach Tikva1 Hematology, Rabin Medical Center, Petach Tikva4 Virology Laboratory5 Hematology, Rambam Health Care Campus5 Hematology, Rambam Health Care Campus5 Hematology, Rambam Health Care Campus5 Hematology, Rambam Health Care Campus5 Hematology, Rambam Health Care Campus5 Hematology, Rambam Health Care Campus7 Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona7 Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona8 Hematology laboratories, Rambam Health Care Campus, Haifa, Israel8 Hematology laboratories, Rambam Health Care Campus, Haifa, Israel8 Hematology laboratories, Rambam Health Care Campus, Haifa, Israel5 Hematology, Rambam Health Care Campus5 Hematology, Rambam Health Care Campushttp://journals.lww.com/10.1097/01.HS9.0000849192.25628.25 |
| spellingShingle | R. Gurion U. Rozovski G. Itchaki A. Gafter-Gvili C. Leibovitch P. Raanani M. Szwarcwort M. Taylor-Abigadol E. Dann N. Horesh T. Inbar I. Tzoran N. Lavi E. Bar Haim H. Cohen I. Slouzky T. Azoulay M. Karmona S. Ringelstein-Harlev N. A. Horowitz P1584: CELLULAR IMMUNE RESPONSE TO THE BNT162B2 VACCINE IN LYMPHOMA PATIENTS HemaSphere |
| title | P1584: CELLULAR IMMUNE RESPONSE TO THE BNT162B2 VACCINE IN LYMPHOMA PATIENTS |
| title_full | P1584: CELLULAR IMMUNE RESPONSE TO THE BNT162B2 VACCINE IN LYMPHOMA PATIENTS |
| title_fullStr | P1584: CELLULAR IMMUNE RESPONSE TO THE BNT162B2 VACCINE IN LYMPHOMA PATIENTS |
| title_full_unstemmed | P1584: CELLULAR IMMUNE RESPONSE TO THE BNT162B2 VACCINE IN LYMPHOMA PATIENTS |
| title_short | P1584: CELLULAR IMMUNE RESPONSE TO THE BNT162B2 VACCINE IN LYMPHOMA PATIENTS |
| title_sort | p1584 cellular immune response to the bnt162b2 vaccine in lymphoma patients |
| url | http://journals.lww.com/10.1097/01.HS9.0000849192.25628.25 |
| work_keys_str_mv | AT rgurion p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT urozovski p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT gitchaki p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT agaftergvili p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT cleibovitch p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT praanani p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT mszwarcwort p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT mtaylorabigadol p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT edann p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT nhoresh p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT tinbar p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT itzoran p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT nlavi p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT ebarhaim p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT hcohen p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT islouzky p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT tazoulay p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT mkarmona p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT sringelsteinharlev p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients AT nahorowitz p1584cellularimmuneresponsetothebnt162b2vaccineinlymphomapatients |